Publicações

Everolimus (Eve) plus Letrozole (Let) in Patients (Pts) with Estrogen Receptor-Positive (Er plus ), Human Epidermal Growth Factor Receptor 2-Negative (Her2-) Advanced Breast Cancer (Abc): Progression-Free Survival (Pfs) Subgroup Analyses in Bolero-4

AuthID
P-00N-2XN

Author(s)

Bachelot, T

Royce, M

Villanueva, C

Melo Cruz, FM

Hegg, R

Falkson, C

Jeong, J

Srimuninnimit, V

Arce, CH

Ridolfi, A

Lin, C

Gradishar, W

Ozguroglu, M

Cardoso, F

Azevedo, S

Tipo de Documento

Abstract

Year published

2017

Publicado

in ANNALS OF ONCOLOGY, ISSN: 0923-7534

Volume: 28

Conference

42Nd European-Society-For-Medical-Oncology Congress (Esmo), Date: SEP 08-12, 2017, Location: Madrid, SPAIN, Patrocinadores: European Soc Med Oncol

Indexing

Wos^®

Metadata
Fontes

Publication Identifiers

Wos: WOS:000411324000233

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Everolimus (Eve) plus Letrozole (Let) in Patients (Pts) with Estrogen Receptor-Positive (Er plus ), Human Epidermal Growth Factor Receptor 2-Negative (Her2-) Advanced Breast Cancer (Abc): Progression-Free Survival (Pfs) Subgroup Analyses in Bolero-4

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Everolimus (Eve) plus Letrozole (Let) in Patients (Pts) with Estrogen Receptor-Positive (Er plus ), Human Epidermal Growth Factor Receptor 2-Negative (Her2-) Advanced Breast Cancer (Abc): Progression-Free Survival (Pfs) Subgroup Analyses in Bolero-4

Links Úteis

Ajuda